OPRM1 and Respiratory insufficiency due to muscle weakness: The analgesic activity of MOR agonists is mediated by G-protein signaling, while many of the undesirable side effects of MOR full agonists, such as respiratory depression, constipation, sedation, and addiction, are thought to be mediated through β-arrestin signaling [26].